Please provide your email address to receive an email when new articles are posted on . In 73% of patients with skin of color, PASI 90 was achieved with secukinumab treatment. Patient-reported ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved an intravenous formulation of Cosentyx for use in patients with psoriatic arthritis, ...
The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections for treating various inflammatory conditions in adults and, in some cases, children. Cosentyx may treat moderate ...
The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections to treat several inflammatory conditions. Adults and certain children can receive this medication to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results